SCHOTT Pharma

SCHOTT Pharma

Arzneimittelherstellung

Mainz, Rheinland-Pfalz 36.395 Follower:innen

We design solutions grounded in science to ensure medicines are safe and easy to use for people around the world.

Info

SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. The portfolio comprises drug containment and delivery solutions for injectable drugs ranging from prefillable glass and polymer syringes, to cartridges, vials, and ampoules. Every day, a team of around 4,700 people from over 65 nations works at SCHOTT Pharma to contribute to global healthcare. The company is represented in all main pharmaceutical hubs with 17 manufacturing sites in Europe, North and South America, and Asia. With over 900 patents and technologies developed in-house, a state-of-the-art R&D center in Switzerland, and around 130 employees in R&D, the company is focused on developing innovations for the future. SCHOTT Pharma AG & Co. KGaA, headquartered in Mainz, Germany, is part of SCHOTT AG that is owned by the Carl Zeiss Foundation. In light of this spirit, SCHOTT Pharma is committed to sustainable development for society and the environment and has the strategic goal of becoming climate-neutral by 2030. Currently, SCHOTT Pharma has over 1,700 customers including the top 30 leading pharma manufacturers for injectable drugs and generated sales of EUR 650 million in the fiscal year 2021. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social

Website
https://www.schott-pharma.com/
Branche
Arzneimittelherstellung
Größe
1.001–5.000 Beschäftigte
Hauptsitz
Mainz, Rheinland-Pfalz
Art
Kapitalgesellschaft (AG, GmbH, UG etc.)
Gegründet
1884
Spezialgebiete
Vials, Cartridges, Syringes, Ampoules, Polymer, Ready to use, Extractables & Leachables, Mechanical Stability, Fractography, Breakage Analysis, Strength Testing, Stress Analysis, Chemical Durability, Delamination Screening, Particle Analysis, Polymer Syringes, Glass Syringes, Pharma und Health

Produkte

Orte

Beschäftigte von SCHOTT Pharma

Updates

  • Unternehmensseite von SCHOTT Pharma anzeigen, Grafik

    36.395 Follower:innen

    Driving subcutaneous self-injection of large-volume doses: Exciting news! 🎉 We are proud to announce the expansion of our ready-to-use platform with cartriQ® Large Volume cartridges. Combined with Ypsomed AG’s device YpsoDose, we introduce the market’s first prefilled and pre-loaded solution. With cartriQ® 10 ml for on-body devices, patients can now self-administer large volumes of highly sensitive biologics conveniently at home. That makes cartriQ® 10 ml a real game-changer: Simplified handling ✅ Enhancing patient convenience and safety ✅ AND reducing healthcare costs as a homecare solution ✅   Read more about how SCHOTT Pharma is leading the way in homecare solutions: https://lnkd.in/eifQABWc   #cartridge #pharma #innovation #biologics #SCHOTTPharma

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von SCHOTT Pharma anzeigen, Grafik

    36.395 Follower:innen

    It is the one month anniversary of our new production site in Hungary. 🎉 It is time to discuss prefillable glass syringes (PFS) with Isabel Deister, SCHOTT Pharma's Head of Business Development for Glass Syringes. We had some questions, and she was kind enough to answer them during a coffee break. Isabel Deister explains one reason customers should buy PFS from SCHOTT Pharma. She also reminisces about the biggest advantage of having a new production site and gives an outlook on what's next in the SCHOTT Pharma glass PFS portfolio.   Get her insights in the slideshow. ➡️   #syringes #SCHOTTPharma #Hungary #BecauseHumanHealthMatters

  • Unternehmensseite von SCHOTT Pharma anzeigen, Grafik

    36.395 Follower:innen

    ✨Exciting news alert! ✨   More than 25 experts from Merck Group, SCHOTT Pharma, and SCHOTT participated in this cross-company exchange for an Environment Health and Safety (EHS) and Sustainability workshop in Mainz   During the workshop, we had the opportunity to tour the tubing production and engage in insightful discussions on EHS and sustainability. 🌱   The collaborative atmosphere not only fostered new ideas but also sparked inspiration, leaving a lasting impact on all involved. It was indeed a rewarding experience to share knowledge and expertise with such a dedicated group of professionals. We are grateful for the open and cooperative exchange that took place, leading to fresh perspectives on these important topics.   A special shoutout to SCHOTT Pharma’s Tobias Kaelber, David Klein, Philipp Ludihuser, Christian Steiner, Tobias Wagner, and Cora Woods for their valuable contributions to the workshop. Together, we are making a difference in EHS and sustainability.   Let's continue to work together towards a more sustainable future! 🤝 🌍   #Sustainability #Innovation #Collaboration #Workshop #SCHOTTPharma

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von SCHOTT Pharma anzeigen, Grafik

    36.395 Follower:innen

    Are you curious about what SCHOTT Pharma ampoules are made of? 🔎   SCHOTT Pharma ampoules are manufactured with 𝗙𝗜𝗢𝗟𝗔𝗫® Type I glass and are available in different glass variants. The high chemical resistance and the excellent surface properties of 𝗙𝗜𝗢𝗟𝗔𝗫® glass ensure that medicines packed in ampoules remain safe at all times.   𝗙𝗜𝗢𝗟𝗔𝗫® clear offers outstanding chemical and hydrolytic resistance, impermeability, and neutrality. 𝗙𝗜𝗢𝗟𝗔𝗫® amber is a colored glass with a proven track record for securing the long-term stability of light-sensitive drugs.   Which one is the right option for you? We help you choose! Don't hesitate to contact us to talk about SCHOTT Pharma glass ampoules. 💡   Read more about 𝗙𝗜𝗢𝗟𝗔𝗫® here: https://lnkd.in/eNNs3A43   #ampoules #SCHOTTPharma #pharmapackaging #drugcontainmentsolution

    Pharmaceutical Type 1 Glass Tubing | SCHOTT

    Pharmaceutical Type 1 Glass Tubing | SCHOTT

    schott.com

  • Unternehmensseite von SCHOTT Pharma anzeigen, Grafik

    36.395 Follower:innen

    What is Helium leak testing? Helium leak testing is one of the common methods to guarantee Container Closure Integrity (CCI). This technique involves introducing helium gas into the container and utilizing a mass spectrometer to identify leaks. Helium leak testing provides an effective way to evaluate the seal integrity of containers that may have been tampered with or damaged. It is particularly beneficial for containers that are having challenges with alternative testing methods.   Read more about this topic here: https://lnkd.in/enZ4dcF8   #pharmaceuticalpackaging #pharmaceuticals #SCHOTTPharma

  • Unternehmensseite von SCHOTT Pharma anzeigen, Grafik

    36.395 Follower:innen

    Many factors influence stability during drug development, including buffer systems, pH range, post-treatments such as terminal sterilization, or storage conditions, which cannot be foreseen or assessed at the beginning of the process. EVERIC® pure offers a safe platform that provides a broader range of formulation options, potentially avoids additional re-formulation cycles if one formulation fails, resulting in a faster time-to-market.   #vials #biologics #EVERIC #SCHOTTPharma

  • Unternehmensseite von SCHOTT Pharma anzeigen, Grafik

    36.395 Follower:innen

    We proudly announce that the SCHOTT TOPPAC® cosmetic polymer prefillable syringe has been awarded the 𝗦𝗶𝗹𝘃𝗲𝗿 𝗪𝗶𝗻𝗻𝗲𝗿 for Medical Aesthetic Innovation Packaging at the CPHI China Pharma Awards 2024! 🥈🎉   Following our previous successes as the 𝟭𝘀𝘁 𝗥𝘂𝗻𝗻𝗲𝗿 𝗨𝗽 𝗳𝗼𝗿 𝗙𝘂𝗻𝗰𝘁𝗶𝗼𝗻𝗮𝗹𝗶𝘁𝘆 and 𝟭𝘀𝘁 𝗥𝘂𝗻𝗻𝗲𝗿 𝗨𝗽 𝗳𝗼𝗿 𝗠𝗮𝗿𝗸𝗲𝘁 𝗣𝗼𝘁𝗲𝗻𝘁𝗶𝗮𝗹 at the InnoPack Pharma Confex Awards, this recognition further underscores our commitment to excellence and innovation in pharmaceutical packaging.   A big 𝗧𝗵𝗮𝗻𝗸 𝘆𝗼𝘂 to our dedicated team and partners for their continuous support. Working together on SCHOTT TOPPAC® cosmetic, we make cosmetic treatments as simple and comfortable as possible for both doctors and patients. Because human health matters.   #pharma #innovation #PFS #syringe #PharmaAwards

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von SCHOTT Pharma anzeigen, Grafik

    36.395 Follower:innen

    The first half of 2024 is in the books: We just published our financial results for the second quarter of fiscal year 2024. 🚀 Revenues: EUR 247m (+11% yoy at constant currencies) 🚀 EBITDA margin: 27.0% (at constant currencies) 🚀 Guidance for 2024 confirmed We continue to move forward with strength and remain committed to our strategic focus on #innovation and #expansion. We have recently announced our collaboration with KORU Medical Systems to advance large volume subcutaneous infusion therapies and have extended our functional service offering as an independent lab. On top, we recently inaugurated our new site for prefillable glass syringes in Hungary and shared the news about our plans to expand in the U.S. with a new production facility for prefillable glass and polymer syringes. Together with our fantastic team of experts, we're ready to meet our customers' needs! #BecauseHumanHealthMatters

  • Unternehmensseite von SCHOTT Pharma anzeigen, Grafik

    36.395 Follower:innen

    Safeguard the credibility and trustworthiness of your analytical testing results. 🚀   We acknowledge the importance of reliable data in design validation to make sure no unforeseen complications occur after launch of your parenteral drug product and thus to secure continuous commercial success. As a third-party independent laboratory for analytical testing of primary packaging and drug-container interaction, SCHOTT Pharma holds accreditation and FDA registration backed by 40+ years of experience. Our stringent documentation standards ensure compliance with authority expectations, and our esteemed reputation with regulatory bodies supports credibility to your submission data.    Analytics made easy – by SCHOTT Pharma. Learn more here: https://lnkd.in/eavJtxtG   #labtesting #analytics #pharma #SCHOTTPharma

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von SCHOTT Pharma anzeigen, Grafik

    36.395 Follower:innen

    We are still buzzing from opening our new prefillable glass syringe production facility in Hungary. 🎉   We are privileged to share more insights from Balazs Vizi, our Head of European Operation and SCHOTT Pharma Hungary plant manager. Over a coffee break, he graciously answered our questions.   ✔️What was the biggest challenge of producing a new glass container in Hungary? ✔️How many new employees were hired by SCHOTT Pharma Hungary to produce PFS? ✔️What was the most significant achievement in producing glass syringes in Hungary?   ➡️ Enjoy reading his answers by clicking through the slideshow!   #syringes #SCHOTTPharma #Hungary #BecauseHumanHealthMatters

Verbundene Seiten

Ähnliche Seiten

Jobs durchsuchen